Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy

Author: Ahlgren G.   Pedersen K.   Lundberg S.   Aus G.   Hugosson J.   Abrahamsson P.-A.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.54, Iss.2, 1999-08, pp. : 329-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content